All In Biotech

Drug Trial Radar · NCT00216346

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis

Last checked: Nov 20, 2026Latest source record: Oct 3, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 667 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

667

Actual

Start

Jun 2003

Primary completion

Not stated

Study completion Nov 2004

Sponsor

Lead sponsor
PATHAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
World Health Organization
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 5 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Symptomatic Visceral Leishmaniasis(VL)is fatal; Due to the increasing resistance to standard therapy with antimonials, there is a need for new safe, efficacious, low-cost therapies for the treatment of VL. Paromomycin is an off-patent aminoglycoside antibiotic with anti-leishmaniasis activity. This study will test the safety and efficacy of paromomycin in the treatment of patients with VL in India.

Conditions

  • Visceral Leishmaniasis

Interventions

  • Paromomycin sulfateDrug

  • Amphotericin BDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. (1) To compare the safety of injectable paromomycin to amphotericin B when administered in the proposed dosage regimens.
  2. (2) To compare the efficacy of injectable paromomycin to amphotericin B with regards to final cure rates.

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Rajendra Memorial Research Institute of Medical Sciences (ICMR)

    Agam Kuan, Patna, Bihar, India

  • Kalazar Research Centre

    Brahmpura, Muzaffarpur, Bihar, India

  • Kalazar Research Centre

    Patna, Bihar, India

  • Kala-azar Medical Research Centre

    Rambagh Road Muzaffarpur, Bihar, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.